Digitale Bibliotheek
Sluiten
Bladeren door artikelen uit een tijdschrift
Zoeken naar
Tijdschrift
Artikel
ISSN
NBN artikel
NBN tijdschrift
DARE/NARCIS document
met titel:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Tijdschrift beschrijving
Alle jaargangen van het bijbehorende tijdschrift
Alle afleveringen van het bijbehorende jaargang
Alle artikelen van de bijbehorende aflevering
78 gevonden resultaten
nr
titel
auteur
tijdschrift
jaar
jaarg.
afl.
pagina('s)
type
1
ACP releases guidelines for fracture prevention in osteoporosis
2008
1657
1
p. 3
artikel
2
Adecatumumab an advantage for some with MBC
2008
1657
1
p. 10
artikel
3
ADRs to local anaesthetics: review of French database
2008
1657
1
p. 21
artikel
4
Alemtuzumab shows further benefits over INF-β-1b for RRMS
2008
1657
1
p. 11
artikel
5
Alitretinoin approved in Denmark.
2008
1657
1
p. 21
artikel
6
All eyes on candesartan in diabetes: new results from DIRECT
2008
1657
1
p. 15
artikel
7
Anti-atherogenic approach with irbesartan/pravastatin?
2008
1657
1
p. 18
artikel
8
Anticoagulant sales likely to double over next decade
2008
1657
1
p. 22
artikel
9
Atropine prevents, reverses negative chronotropic effect of fingolimod
2008
1657
1
p. 8
artikel
10
BA 210 granted orphan drug status in the EU.
2008
1657
1
p. 22
artikel
11
Bicalutamide receives additional exclusivity in the US.
2008
1657
1
p. 22
artikel
12
Botulinum toxin A a no-brainer for chronic migraine
2008
1657
1
p. 14
artikel
13
Bucindolol BEST in HF patients with `very favourable' genotypes
2008
1657
1
p. 10
artikel
14
Can clinical research ever be truly independent?
2008
1657
1
p. 3
artikel
15
Cetuximab extends survival in patients with mCRC
2008
1657
1
p. 14
artikel
16
Cetuximab failure means bevacizumab still best biologic
2008
1657
1
p. 16
artikel
17
Cetuximab improves OS in head and neck cancer
2008
1657
1
p. 17
artikel
18
Cetuximab launched in Japan for advanced colorectal cancer
2008
1657
1
p. 23
artikel
19
Chronic migraine still cramping patients' style
2008
1657
1
p. 5
artikel
20
Cinacalcet improves BMD in renal transplant recipients with hyperparathyroidism
2008
1657
1
p. 16
artikel
21
Consolidative immunotherapy in chemoresponsive sarcomas
2008
1657
1
p. 8
artikel
22
Continuous adalimumab most beneficial in psoriasis
2008
1657
1
p. 14
artikel
23
Crofelemer effective in the treatment of cholera
2008
1657
1
p. 13
artikel
24
Denosumab STANDs to give patients FREEDOM to DECIDE
2008
1657
1
p. 7-8
artikel
25
Encouraging results with EndoTAG-1 in pancreatic cancer
2008
1657
1
p. 10
artikel
26
Enzyme replacement therapy granted orphan drug designation.
2008
1657
1
p. 21
artikel
27
Everolimus NETs RADIANT results in phase II trial
2008
1657
1
p. 17
artikel
28
Everolimus + octreotide promising in neuroendocrine tumours
2008
1657
1
p. 10
artikel
29
Everolimus sets new RECORDs for advanced renal cancer
2008
1657
1
p. 18
artikel
30
Fingolimod finds favour in MS
2008
1657
1
p. 12
artikel
31
Fougera's generic antifungal cream approved by US FDA.
2008
1657
1
p. 22
artikel
32
Further evidence for fampridine use in treating MS
2008
1657
1
p. 9
artikel
33
Further findings for interferon-beta-1a in RRMS
2008
1657
1
p. 17
artikel
34
Generic alendronic acid given the OK in the US.
2008
1657
1
p. 22
artikel
35
Generic levodopa/carbidopa approved in the US.
2008
1657
1
p. 22
artikel
36
Generic protriptyline tablets approved in US.
2008
1657
1
p. 22
artikel
37
Generic version of Janssen's Risperdal approved in the US.
2008
1657
1
p. 22
artikel
38
Gene therapy holds hope for Duchenne muscular dystrophy
2008
1657
1
p. 8
artikel
39
Glatiramer acetate good news for MS
2008
1657
1
p. 16
artikel
40
Glycopyrrolate effective as treatment for sialorrhoea
2008
1657
1
p. 13
artikel
41
Golotimod shows encouraging antiviral activity in HCV
2008
1657
1
p. 12
artikel
42
Hypophosphataemia drug candidate gets orphan status in US.
2008
1657
1
p. 22
artikel
43
Inconclusive results for ispronicline in AD
2008
1657
1
p. 11
artikel
44
Increased mortality with epoetin-α in stroke patients
2008
1657
1
p. 19
artikel
45
Inhaled insulin blows away insulin injections
2008
1657
1
p. 16
artikel
46
Iobenguane approved for detection of rare endocrine tumours.
2008
1657
1
p. 23
artikel
47
Ipilimumab extends survival in advanced melanoma
2008
1657
1
p. 9
artikel
48
Longterm androgen deprivation therapy has a cost
2008
1657
1
p. 2
artikel
49
Long-term betacarotene improves memory
2008
1657
1
p. 18
artikel
50
Macromolecular polymer equivalent to heparin coating
2008
1657
1
p. 14
artikel
51
Maternal influenza immunisation pays off for mums and kids
2008
1657
1
p. 1
artikel
52
MF 101 promising for menopausal hot flashes
2008
1657
1
p. 8
artikel
53
More seeds of doubt sewn about integrity of big pharma
2008
1657
1
p. 2
artikel
54
Natalizumab in MS well tolerated
2008
1657
1
p. 18
artikel
55
New Canadian diabetes guidelines include DPP-IV inhibitors
2008
1657
1
p. 2
artikel
56
Nicardipine injection introduced in the US.
2008
1657
1
p. 22
artikel
57
Novel vaccine show promise for relapsing-remitting MS
2008
1657
1
p. 12
artikel
58
NX 1207 shows positive effect in BPH
2008
1657
1
p. 12
artikel
59
Odanacatib opportune for osteoporosis
2008
1657
1
p. 9
artikel
60
Olanzapine increases FASN and SCD gene expression in blood cells
2008
1657
1
p. 20
artikel
61
Paracetamol a risk factor for asthma in childhood?
2008
1657
1
p. 20
artikel
62
Paracetamol + ibuprofen best option in paediatric fever?
2008
1657
1
p. 4
artikel
63
Pazopanib a new weapon in the anti-cancer arsenal
2008
1657
1
p. 6
artikel
64
PharmacoEconomics issue on overcoming `fourth hurdle' (NICE)
2008
1657
1
p. 5
artikel
65
PPI interaction makes clopidogrel less effective
2008
1657
1
p. 20
artikel
66
Ranbaxy medicines come under scrutiny after FDA audit
2008
1657
1
p. 21
artikel
67
Sertraline improves depression, reduces HF mortality
2008
1657
1
p. 19
artikel
68
Silibinin reduces serum ferritin levels in chronic hepatitis C
2008
1657
1
p. 6
artikel
69
Solifenacin economically dominant in OAB
2008
1657
1
p. 4
artikel
70
Somatropin efficacy comparable with existing therapies
2008
1657
1
p. 16
artikel
71
Tafluprost reduces intraocular pressure in healthy volunteers
2008
1657
1
p. 8
artikel
72
The ORACLEs speak . . . and it is not good news
2008
1657
1
p. 19
artikel
73
TH 9402 receives orphan drug designation in EU.
2008
1657
1
p. 23
artikel
74
Trabectedin triumphs in ovarian cancer
2008
1657
1
p. 11
artikel
75
TT 223 phase II trial in type 2 diabetes underway
2008
1657
1
p. 13
artikel
76
Unit dose budesonide trial completes enrolment
2008
1657
1
p. 6
artikel
77
Vitamin B12 may protect the brain in old age
2008
1657
1
p. 6
artikel
78
Zoledronic acid shows potential anticancer benefits
2008
1657
1
p. 13
artikel
78 gevonden resultaten
Koninklijke Bibliotheek -
Nationale Bibliotheek van Nederland